The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
|Articles|May 10, 2011
FDA Sends Warning Letter over Health Claims Made on Facebook
The letter also accuses the company of making similar disease claims on its own website, www.aloeelite.com.
Advertisement
According to the warning letter, sent to the company Organic Ease Inc. on March 30 regarding its AloeElite supplement, on the company’s Facebook page it claims: “AloeElite is an all-natural supplement used to treat moderate to severe digestive disorders such as Ulcerative Colitis, Crohn’s disease, IBS, diverticulitis, and a host of other conditions.” It is unlawful for dietary supplement products to make disease-treatment claims.
The letter also accuses the company of making similar disease claims on its own website,
*Nutritional Outlook thanks Justin J. Prochnow of Greenberg Traurig LLP for the tip.
Advertisement
Related to this article
AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.
The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.
The proposed notification requirement is straightforward, but its legal and commercial consequences are not.
The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5